US Market Research

US Market Research

Possible Sanofi Targets?

May 24, 2025
∙ Paid
Share

Last week Sanofi acquired Vigal neuroscience for $8.00 + CVR. Sanofi entered a convertible partnership agreement last year at $7.44/share so essentially it paid itself a premium of 56 cents.

VIGL!

I did a cursory EDGAR search to find other stocks Sanofi has partnered with. Here is the list. It is not exhaustive I am sure I missed some legacy deals.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Gravity Analytica Capital LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture